192 related articles for article (PubMed ID: 30061637)
1. Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways.
Ohno Y; Shingyoku S; Miyake S; Tanaka A; Fudesaka S; Shimizu Y; Yoshifuji A; Yamawaki Y; Yoshida S; Tanaka S; Sakura K; Tanaka T
Oncogene; 2018 Dec; 37(49):6357-6367. PubMed ID: 30061637
[TBL] [Abstract][Full Text] [Related]
2. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells.
Morrison BJ; Steel JC; Morris JC
PLoS One; 2012; 7(11):e49752. PubMed ID: 23152931
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells.
Liu J; Xiao Z; Wong SK; Tin VP; Ho KY; Wang J; Sham MH; Wong MP
Oncotarget; 2013 Oct; 4(10):1698-1711. PubMed ID: 24091605
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.
Cortes-Dericks L; Froment L; Boesch R; Schmid RA; Karoubi G
BMC Cancer; 2014 Apr; 14():304. PubMed ID: 24884875
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population.
Yasuda K; Torigoe T; Morita R; Kuroda T; Takahashi A; Matsuzaki J; Kochin V; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N
PLoS One; 2013; 8(8):e68187. PubMed ID: 23967051
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells.
Pattarozzi A; Carra E; Favoni RE; Würth R; Marubbi D; Filiberti RA; Mutti L; Florio T; Barbieri F; Daga A
Stem Cell Res Ther; 2017 May; 8(1):119. PubMed ID: 28545562
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents.
Pasdar EA; Smits M; Stapelberg M; Bajzikova M; Stantic M; Goodwin J; Yan B; Stursa J; Kovarova J; Sachaphibulkij K; Bezawork-Geleta A; Sobol M; Filimonenko A; Tomasetti M; Zobalova R; Hozak P; Dong LF; Neuzil J
PLoS One; 2015; 10(5):e0119549. PubMed ID: 25932953
[TBL] [Abstract][Full Text] [Related]
8. CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
Lun SW; Cheung ST; Cheung PF; To KF; Woo JK; Choy KW; Chow C; Cheung CC; Chung GT; Cheng AS; Ko CW; Tsao SW; Busson P; Ng MH; Lo KW
PLoS One; 2012; 7(12):e52426. PubMed ID: 23285037
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
[TBL] [Abstract][Full Text] [Related]
11. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
[TBL] [Abstract][Full Text] [Related]
12. Identification of gastric cancer stem cells using the cell surface marker CD44.
Takaishi S; Okumura T; Tu S; Wang SS; Shibata W; Vigneshwaran R; Gordon SA; Shimada Y; Wang TC
Stem Cells; 2009 May; 27(5):1006-20. PubMed ID: 19415765
[TBL] [Abstract][Full Text] [Related]
13. Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells.
Ohata H; Ishiguro T; Aihara Y; Sato A; Sakai H; Sekine S; Taniguchi H; Akasu T; Fujita S; Nakagama H; Okamoto K
Cancer Res; 2012 Oct; 72(19):5101-10. PubMed ID: 23002207
[TBL] [Abstract][Full Text] [Related]
14. LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells.
Wang L; Hirohashi Y; Ogawa T; Shen M; Takeda R; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
Biochem Biophys Res Commun; 2017 Apr; 486(2):232-238. PubMed ID: 28238780
[TBL] [Abstract][Full Text] [Related]
15. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
[TBL] [Abstract][Full Text] [Related]
17. Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies.
Fan CW; Chen T; Shang YN; Gu YZ; Zhang SL; Lu R; OuYang SR; Zhou X; Li Y; Meng WT; Hu JK; Lu Y; Sun XF; Bu H; Zhou ZG; Mo XM
Cell Death Dis; 2013 Oct; 4(10):e828. PubMed ID: 24091671
[TBL] [Abstract][Full Text] [Related]
18. Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal.
Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Fujino J; Tamura Y; Tsukahara T; Kanaseki T; Kobayashi J; Sasaki T; Takahashi A; Nakamori K; Yamaguchi A; Hiratsuka H; Sato N
Biochem Biophys Res Commun; 2013 Sep; 439(1):96-102. PubMed ID: 23954638
[TBL] [Abstract][Full Text] [Related]
19. Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines.
Michishita M; Akiyoshi R; Suemizu H; Nakagawa T; Sasaki N; Takemitsu H; Arai T; Takahashi K
Vet J; 2012 Aug; 193(2):508-13. PubMed ID: 22326935
[TBL] [Abstract][Full Text] [Related]
20. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma.
Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S
J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
